Modernatx, Inc.

This study tested a new mRNA vaccine, mRNA-1345, designed to protect against Respiratory Syncytial Virus (RSV) in adults aged 50 and older. Researchers wanted to see if it was safe and effective when given by itself, or at the same time as a seasonal flu shot or a COVID-19 booste…

This large study tested a new mRNA-based seasonal flu vaccine (mRNA-1010) against a standard, already-approved flu shot. It aimed to see if the new vaccine is as safe and effective at preventing the flu in adults aged 50 and older. Over 40,000 participants received either the new…

This study tested the Moderna mRNA COVID-19 vaccine in healthy adolescents aged 12 to 18. Its main goals were to check the vaccine's safety, side effects, and how well it protects against COVID-19. Over 4,300 teens participated, receiving either the vaccine or a placebo shot, wit…

This study tested the safety and immune response of several Moderna mRNA vaccines designed to protect against four different viruses: COVID-19, seasonal flu, respiratory syncytial virus (RSV), and cytomegalovirus (CMV). It involved 308 healthy adults aged 18 to 75. The main goal …

This study tested a single vaccine, called mRNA-1083, designed to protect against both seasonal influenza and COVID-19. It involved 932 adults aged 50 to 65 to check the vaccine's safety and how well it triggers an immune response. The goal is to see if one injection can simplify…

This study tested a new vaccine, mRNA-1083, designed to protect against both seasonal flu and COVID-19 with a single shot. It involved 1,320 healthy adults aged 18 to 65 to see how well their immune systems responded and to check for side effects. The goal was to see if this comb…

This study tested a new mRNA vaccine designed to protect against both seasonal influenza and COVID-19 in a single shot. It involved over 1,700 healthy adults and aimed to find the safest and most effective dose. The main goals were to check for side effects and measure how well t…

This study followed adults who had previously received an experimental CMV vaccine to see how long their immune protection lasted. Some participants later received a booster dose to see if it safely renewed their protection. The goal was to understand the vaccine's long-term safe…

This study tested a new Moderna vaccine designed to protect against both COVID-19 and seasonal influenza with a single injection. It involved over 2,400 healthy adults aged 50 and older in Asia. The main goal was to see how well the body's immune system responded to the combined …

This study tested updated Moderna COVID-19 vaccines designed to protect against newer virus variants in children from 6 months to under 6 years old. Researchers enrolled about 1,800 children to check how safe the vaccines are and how well they trigger an immune response. The stud…

This study tested a new flu vaccine made with mRNA technology, similar to Moderna's COVID-19 vaccine. It involved 172 healthy adults and compared the new vaccine's safety and ability to trigger an immune response against standard flu shots. The main goal was to see if the mRNA va…

This study tested the safety and immune response of an experimental mRNA vaccine (mRNA-1893) designed to prevent Zika virus infection. It involved 808 healthy adults, some with and some without prior exposure to similar viruses like dengue. Researchers compared two different vacc…

This study tested two new mRNA vaccine candidates designed to prevent Lyme disease. It involved 807 healthy adults to see if the vaccines were safe and if they triggered a good immune response against the bacteria that causes Lyme. The study compared different doses of the vaccin…

This study aimed to check if Moderna's updated COVID-19 booster vaccine affects levels of a protein in the blood that can indicate heart stress. Researchers enrolled 1,000 healthy participants aged 12 to 30 and measured this protein before and after vaccination, comparing results…